Guidelines for the prevention, diagnosis and treatment of Infertility
The World Health Organization (WHO) has published, for the first time in its history, a Global Guideline on Infertility, an extensively anticipated document within the medical and scientific communities. Built through robust systematic reviews, rigorous evidence appraisal, and broad international collaboration, the guideline establishes unprecedented global standards for the prevention, diagnosis, and treatment of infertility.
MedEA – Medical Education Academy is proud to highlight the central role played by Prof. Dr. Sandro C. Esteves, member of the Scientific Committee for both Female and Male Infertility, and Head of the Male Infertility Subarea.
In addition to his work on the WHO guideline, Prof. Esteves is recognised for his role in developing two major classification systems in reproductive medicine:
• the POSEIDON criteria, which transformed the assessment and management of low-prognosis women undergoing ART, and
• the APHRODITE criteria, an emerging framework that modernises the approach to male infertility by integrating physiology, endocrine profiles, and personalised therapeutic strategies.
The guideline emphasises that semen analysis, while fundamental, is not sufficient on its own. A thorough clinical evaluation — including detailed medical, reproductive, and sexual history and physical examination — is essential.
Lifestyle modification, smoking cessation, prevention and treatment of sexually transmitted infections, and general health promotion are highlighted as pillars of male reproductive health.
The WHO found insufficient evidence to recommend for or against antioxidant therapy, underscoring the need for high-quality research in this area.
The guideline recommends treatment exclusively for clinical (palpable) varicocele, supported by consistent evidence of benefit. Subclinical varicocele (detected only by imaging) was not recommended due to lack of demonstrable improvement in reproductive outcomes.
Diagnostic pathways adaptable to different healthcare settings were included, facilitating consistent clinical practice across regions with varying levels of resources.
This WHO guideline has significant implications for the educational mission of MedEA:
• it consolidates infertility care teaching based on current, internationally validated evidence;
• it encourages alignment of clinical practice across countries;
• it enhances training frameworks, courses, and educational programs targeting infertility;
• it provides an essential new reference for professional development, certification, and continuing medical education.
The contribution of Prof. Esteves reinforces MedEA’s commitment to scientific excellence and the dissemination of high-impact, evidence-based medical knowledge.
“It was an honour to contribute to the development of this historic WHO guideline. The depth of collaboration, quality of evidence, and commitment to equity make this document a true milestone in reproductive healthcare. I believe it will have a direct positive impact on educational and training initiatives, including those led by MedEA.”
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a Fertility Center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the State University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.
He obtained his MD. degree in 1990 from the Faculty of Medical Sciences of UNICAMP, Brazil. Subsequently, he completed his Urology residency at the same institution and a postdoctoral fellowship program at the Glickman’s Urological Institute at the Cleveland Clinic Foundation in the United States. He earned a master’s in Surgery from UNICAMP and a Ph.D. in Urology from the Federal University of S o Paulo (EPM-UNIFESP). Dr. Esteves has contributed to our understanding of male infertility with over 25 years of experience in clinical and academic settings. He has emphasized the limitations of basic semen analysis, the importance of assessing sperm DNA fragmentation in male infertility evaluations, and highlighted the relevance of varicocele and its treatment in enhancing male fertility prospects. He has also published extensively on his clinical experience with microsurgical treatment of infertile men, as well as on hormonal therapy for improving sperm retrieval success of men with non-obstructive azoospermia. Dr. Esteves has helped design novel stratification systems for infertile men with testicular dysfunction, for whom fertility prospects may improve after hormonal therapy, and for low prognosis infertile women undergoing ART. Dr. Esteves is a prolific author, and his research comprises over 350 published papers, numerous book chapters, and textbooks. With a Hirsch index of 71 and a citation count of around 17K, he is ranked among the top 1% of global researchers by the Science-Wide Author Databases of Standard Citation Indicators (Elsevier). Prof. Esteves plays an active role in the scientific community as a member of the Faculty Opinions in reproductive endocrinology and infertility and as a founding member of the POSEIDON group for reproductive medicine. Additionally, he holds positions as Associate Editor/Section Editor in several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He also serves on the editorial boards of many scientific journals, including Nature Reviews Urology. Dr. Esteves’ clinic has been at the forefront of implementing cleanroom technology in the ART laboratory and adhering to ISO 9001 quality standards in Brazil. The ANDROFERT team is renowned for its strict quality standards and remarkable success rates in treating couples with male factor infertility. As a seasoned speaker, Dr. Esteves delivers over 50 lectures annually in Brazil and internationally. He has received multiple research grants and awards from national and international societies and currently holds the position of head of the Department of Andrology at the Brazilian Society of Human Reproduction.